Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Non Operating Income (2021 - 2023)

Historic Non Operating Income for Immuneering (IMRX) over the last 3 years, with Q4 2023 value amounting to $464352.0.

  • Immuneering's Non Operating Income rose 10797.03% to $464352.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year increase of 51531.85%. This contributed to the annual value of $1.3 million for FY2023, which is 51531.29% up from last year.
  • According to the latest figures from Q4 2023, Immuneering's Non Operating Income is $464352.0, which was up 10797.03% from $475595.0 recorded in Q3 2023.
  • Immuneering's 5-year Non Operating Income high stood at $475595.0 for Q3 2023, and its period low was -$118974.0 during Q4 2021.
  • Moreover, its 3-year median value for Non Operating Income was $135514.0 (2022), whereas its average is $142404.8.
  • As far as peak fluctuations go, Immuneering's Non Operating Income soared by 159381.88% in 2022, and later surged by 10797.03% in 2023.
  • Immuneering's Non Operating Income (Quarter) stood at -$118974.0 in 2021, then skyrocketed by 287.67% to $223278.0 in 2022, then soared by 107.97% to $464352.0 in 2023.
  • Its Non Operating Income stands at $464352.0 for Q4 2023, versus $475595.0 for Q3 2023 and $150193.0 for Q2 2023.